RSPT: How This Equal Weight Tech Fund Is Navigating The AI Boom

RSPT's equal-weight structure is drifting toward top-performing AI and chip names between quarterly rebalances, reducing the diversification investors may expect. The article warns that recent outperformance has come from underweighting mega-cap tech and overweighting high-beta AI stocks, but that advantage could reverse if AI spending slows. The message is a cautious risk note rather than a catalyst-driven event.

Analysis

The key second-order issue is that an equal-weight wrapper around a concentrated theme can become a momentum amplifier, not a diversifier. When the basket is dominated by a handful of AI-capex beneficiaries, quarterly reconstitution creates a mechanical buy-high/sell-low pattern that raises the ETF’s effective beta into the very names investors think they are diversifying away from.

That means the real risk is not broad tech drawdown; it is a shift in the market’s internal leadership. If hyperscaler capex growth decelerates or semiconductor order books roll over, the ETF can underperform both cap-weight tech and the market because it is implicitly leaning into the most crowded, valuation-sensitive segment of the complex. The vulnerable window is 1-3 months around earnings and capex guidance, when positioning is most extended and liquidity is thin.

The beneficiary set is broader than the obvious chip leaders: electrical equipment, cooling, networking, and power infrastructure vendors can continue to see order support even if AI software monetization disappoints. But if management teams begin talking about efficiency, utilization, or digestion rather than expansion, the trade can reverse quickly because the marginal buyer has likely been trend-following flows rather than fundamental allocators.

Consensus is missing how little true diversification is left inside “equal weight” products once one theme dominates returns. The trade is not that AI dies; it is that dispersion rises and the basket becomes more fragile than advertised. In that regime, the best relative trades are not outright shorts on technology but hedges against concentrated AI beta and reversion in the most crowded high-multiple names.

Key Decisions for Investors

• Short RSPT vs long XLK as a 1-3 month relative-value hedge: express the view that equal-weight tech is more exposed to AI-beta reversal than cap-weight tech; target a modest mean-reversion move with tight risk controls around earnings season.
• Buy put spreads on RSPT 2-4 months out, ideally into strength: this is a cheaper way to monetize a post-rebalance pullback if AI sentiment cools; structure for a 2-3x payoff in a 5-8% drawdown scenario.
• Pair long infrastructure beneficiaries vs short AI capex leaders over 1-2 quarters: favor names tied to power, cooling, and networking demand while fading the highest-multiple semiconductor/AI hardware complex if capex growth normalizes.
• If already long RSPT, trim ahead of quarterly rebalance and re-add only after earnings/capex commentary clears: the risk/reward is poor when flows are doing the buying for you.
• Watch hyperscaler capex and semiconductor order commentary as the catalyst calendar; any evidence of spending moderation should be treated as a signal to rotate from crowded AI beta into broader software or defensive tech exposure.